• SENSEX 80,918.78
    -266.80 (--0.33%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kerala Ayurveda Ltd Pharmaceuticals - Indian - Formulations

  • MNC Associate
  • BSE Code : 4855.0
  • ISIN : INE817B01025
522.75 -20 (-3.68%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    515.65

  • Today’s High

    553.90

  • Open

    537.00

  • Perv Close

    542.75

  • 52W Low

    250.00

  • 52W High

    625.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    629.00

  • Div & Yield %

    0.00

  • Book Value(₹)

    20.88

  • Debt-Equity Ratio

    -3.68

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    3.71

  • Mar.Cap (₹Cr.)

    629.00

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    12.03

  • BV (₹)

    20.90

  • Sales( ₹ in Cr.)

    72.69

  • NP (in Cr.)

    -13.78

  • NP Var(%)

    -4981.0

  • Div%

    0.0

  • CPS (₹)

    -9.70

  • EPS (₹)

    -11.50

  • Traded Value (₹ in Lakhs)

    629.00

  • 52 Week High

    625.00

  • 52 Week Low

    250.00

  • Price BSE

    523.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    629.00

  • P/C Ratio

    -54.10

  • P/E Ratio

    -45.70

  • Price Vs.BV

    -11.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 73.14 63.30 55.80 43.20 53.68 46.49
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 73.14 63.30 55.80 43.20 53.68 46.49
Other Income 0.16 0.06 0.30 0.17 0.16 1.53
Stock Adjustments 3.32 -0.11 0.27 -1.65 0.36 0.45
Total Income 76.62 63.25 56.37 41.72 54.20 48.47
EXPENDITURE :            
Raw Materials 23.00 17.55 16.37 12.92 13.98 12.45
Power and Fuel Cost 2.26 2.08 2.01 1.09 1.72 1.03
Employee Cost 20.23 15.98 12.17 13.06 16.03 14.34
Other Manufacturing Expenses 4.47 4.06 3.26 3.13 4.52 4.22
Selling and Administration Expenses 20.85 18.21 14.02 11.13 14.50 11.71
Miscellaneous Expenses 0.60 -2.47 0.52 0.01 0.20 0.19
Employee Benefit Expenses 20.23 15.98 12.17 13.06 16.03 14.34
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 71.41 55.42 48.34 41.34 50.94 43.94
Operating Profit 5.22 7.82 8.03 0.38 3.26 4.54
Interest 4.02 4.81 6.03 6.14 1.37 2.23
Gross Profit 1.20 3.01 2.00 -5.76 1.89 2.31
Depreciation 0.77 0.64 0.77 0.82 0.68 0.56
Profit Before Tax 0.43 2.37 1.23 -6.58 1.21 1.75
Current Tax 0.00 0.00 0.00 0.00 0.00 0.64
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.70 -0.52 0.35 -1.63 0.34 -0.09
Reported Net Profit -0.27 2.89 0.89 -4.95 0.88 1.20
Extraordinary Items 0.00 2.43 0.00 0.00 0.00 1.02
Adjusted Net Profit -0.27 0.46 0.89 -4.95 0.88 0.18
Adjustment below Net Profit -0.03 0.37 0.34 0.32 0.30 -5.38
P & L Balance brought forward -8.11 -11.37 -12.60 -7.97 -9.15 -4.97
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -8.41 -8.11 -11.37 -12.60 -7.97 -9.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.23 2.74 0.84 -4.69 0.83 1.14
Earnings Per Share(Adj)-Unit Curr -0.23 2.74 0.84 -4.69 0.83 1.14
Book Value 35.22 13.77 10.68 9.51 13.90 12.78
Book Value(Adj)-Unit Curr 35.22 13.77 10.68 9.51 13.90 12.78

Shareholding Pattern

  • Promoter Group

    37.83%

  • Public Share Holding

    62.17%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 3,996,627 33.22 3,996,627 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,996,627 33.22 3,996,627 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 555,000 4.61 555,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 555,000 4.61 555,000 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,709 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,976 0.02 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 4,685 0.04 0 2
2] Non Institution
Bodies Corporate 1,653,773 13.74 1,644,787 105
Clearing Members 0 0.00 0 0
Directors of their Relatives 208,195 1.73 177,265 8
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 217,465 1.81 75,903 159
Foreign Non Institution Other 25,737 0.21 0 1
Hindu Undivided Families 230,000 1.91 230,000 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,787,921 23.17 2,787,921 26
Individuals holding nominal share capital up to Rs. 1 lakh 2,177,240 18.09 2,034,133 8,932
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 175,808 1.46 175,808 165
Sub Total 7,476,139 62.13 7,125,817 9,397
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,032,451 100.00 11,677,444 9,401

Company Background

Kerala Ayurveda LtdPharmaceuticals - Indian - Formulations

  • Kerala Ayurveda Ltd
  • BSE Code : 4855.0
  • ISIN : INE817B01025

  • Incorporation Year

    1992

  • Registered Office

    VII/415 Nedumbassery
    Athani P O Aluva, Ernakulam,
    Kerala-683585

  • Telephone

    91-484-2476301/2/3/4

  • FAX

    91-484-2474376

  • Chairman

    Ramesh Vangal

  • Managing Director

  • Company Secretary

    Jyothi Gulecha

  • Auditor

    Maharaj Rajan & Mathew

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Integrated Registry Mgt Servic
    Kences Tower ,
    2nd Floor No 1 ,Ramakrishna Street
    Mumbai - Chennai - 600 017

Kerala Ayurveda Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kerala Ayurveda 522.75 73.31 73.14 -60.36 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10